Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-27 @ 5:05 AM
Study NCT ID:
NCT00268450
Status:
TERMINATED
Last Update Posted:
2018-07-12
First Post:
2005-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery
Sponsor:
Medical University of South Carolina
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2012-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-20
First Submit QC Date:
None
Study First Post Date:
2005-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-04
Results First Submit QC Date:
None
Results First Post Date:
2018-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-13
Last Update Post Date:
2018-07-12
Last Update Post Date Type:
ACTUAL